Cathy Burgess was a featured speaker during the session "Recent Trends in Data Integrity Compliance and Enforcement" at this conference hosted by the Food and Drug Law Institute (FDLI). Data integrity is essential for the global biopharma industry. This session offered perspectives from regulators and industry and illustrated how data integrity breaches can have significant effects on the quality, safety and efficacy of medical products. Speakers also discussed the climate of data integrity enforcement, FDA’s approach towards oversight, recent cases, investigations and outcomes.
For more information, please click here.
April 20-21, 2015
Grand Hyatt Washington / Washington, DC
For more information, please click here.
April 20-21, 2015
Grand Hyatt Washington / Washington, DC